Tocilizumab use in pregnancy: Analysis of a global safety database including data from clinical trials and post-marketing data-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Tocilizumab use in pregnancy: Analysis of a global safety database including data from clinical trials and post-marketing data

Published:2016-10 Issue:2 Volume:46 Page:238-245
ISSN:0049-0172
Container-title:Seminars in Arthritis and Rheumatism
language:en
Short-container-title:Seminars in Arthritis and Rheumatism

Author:

Hoeltzenbein Maria,Beck Evelin,Rajwanshi Richa,Gøtestam Skorpen Carina,Berber Erhan,Schaefer Christof,Østensen Monika

Funder

German Ministry of Health

German Federal Institute for Drugs and Medical Devices

Publisher

Elsevier BV

Subject

Anesthesiology and Pain Medicine,Rheumatology

Reference31 articles.

1. Humanized antihuman IL-6 receptor antibody, tocilizumab;Nishimoto;Handb Exp Pharmacol,2008

2. Interleukin-6 receptor inhibition with tocilizumab reduces disease activity in rheumatoid arthritis with inadequate response to disease-modifying antirheumatic drugs: The tocilizumab in combination with traditional disease-modifying antirheumatic drug therapy study

3. IL-6 inhibitors for treatment of rheumatoid arthritis: past, present, and future;Kim;Arch Pharm Res,2015

4. Longterm safety of tocilizumab: results from 3 years of followup postmarketing surveillance of 5573 patients with rheumatoid arthritis in Japan;Yamamoto;J Rheumatol,2015

5. Comparison of tocilizumab monotherapy versus methotrexate monotherapy in patients with moderate to severe rheumatoid arthritis: the AMBITION study;Jones;Ann Rheum Dis,2010

Cited by 120 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Use of interleukin-6 receptor antibodies in the second and third trimester of pregnancy: a retrospective cohort study;The Lancet Rheumatology;2024-09

2. Successful use of tocilizumab and casirivimab/imdevimab in a twin pregnancy with critical COVID-19 – A case report;Heliyon;2024-06

3. Safety of biologic agents for the management of rheumatic diseases during pregnancy;Current Opinion in Rheumatology;2024-03-11

4. The use of tocilizumab in severe COVID-19: A comprehensive review;Medicinska istrazivanja;2024

5. Blockade of IL-6R prevents preterm birth and adverse neonatal outcomes;eBioMedicine;2023-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3